Hydroxyamine

Hydroxyamine

SCHEMBL8521982

C#Cc1scc(C(=O)O)c1N(Cc1ccccc1)S(=O)(=O)c1ccc(OC)cc1.NO

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 15/20 0.60
MMP13 P45452 14/20 0.60
MMP1 P03956 12/20 0.60
NR3C1 P04150 1/20 0.50
PGR P06401 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ADAM17 P78536 3/20 0.49
PTGES O14684 1/20 0.49
TAS2R14 Q9NYV8 1/20 0.49
TAS2R8 Q9NYW2 1/20 0.49
CXCR3 P49682 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6558860 0.98 MMP9 (0.62) MMP9MMP13MMP1NR3C1PGR
SCHEMBL8521983 0.91 MMP9 (0.58) MMP9MMP13MMP1NR3C1PGR
SCHEMBL6559690 0.90 MMP9 (0.63) MMP9MMP13MMP1NR3C1PGR
SCHEMBL7467779 0.89 MMP9 (0.78) MMP9MMP13MMP1ADAM17
SCHEMBL6560148 0.84 MMP9 (0.83) MMP9MMP13MMP1NR3C1PGR
SCHEMBL7463546 0.81 MMP9 (0.59) MMP9MMP13MMP1ADAM17
SCHEMBL7413282 0.81 MMP9 (0.52) MMP9MMP13MMP1NR3C1PGR
SCHEMBL7317676 0.80 MMP13 (0.64) MMP9MMP13MMP1ALDH1A1LMNA
SCHEMBL7351229 0.78 MMP9 (0.81) MMP9MMP13MMP1NR3C1PGR
Hydroxyamine SCHEMBL8521994 0.78 MMP9 (0.58) MMP9MMP13MMP1NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934300-A1 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO HETEROARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS American Cyanamid Company (US) 1999-08-11 EP disclosed
WO-1998016520-A1 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO HETEROARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1998-04-23 WO disclosed